Andrew Berens
Stock Analyst at Leerink Partners
(4.87)
# 339
Out of 4,517 analysts
541
Total ratings
48.8%
Success rate
24.2%
Average return
Main Sectors:
Stocks Rated by Andrew Berens
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AGIO Agios Pharmaceuticals | Maintained: Buy | n/a | $38.72 | - | 52 | Jul 7, 2026 | |
| PBLS Parabilis Medicines | Initiated Coverage: Buy | $40 | $29.06 | +37.65% | 1 | Jul 6, 2026 | |
| AURA Aura Biosciences | Reiterated: Buy | n/a | $6.89 | - | 28 | Jun 2, 2026 | |
| STRO Sutro Biopharma | Rated: Buy | $38 → $43 | $23.73 | +81.21% | 2 | May 15, 2026 | |
| TNGX Tango Therapeutics | Rated: Buy | $10 → $55 | $27.64 | +98.99% | 26 | May 15, 2026 | |
| IMNM Immunome | Maintained: Buy | $40 → $33 | $22.20 | +48.65% | 14 | May 15, 2026 | |
| DMRA Damora Therapeutics | Maintained: Buy | $46 → $51 | $30.24 | +68.65% | 2 | May 15, 2026 | |
| CMPX Compass Therapeutics | Maintained: Buy | $7 → $11 | $2.10 | +423.81% | 26 | Apr 27, 2026 | |
| ANL Adlai Nortye | Initiated Coverage: Buy | $23 | $11.35 | +102.64% | 1 | Mar 20, 2026 | |
| BBOT BridgeBio Oncology Therapeutics | Reiterated: Buy | $41 | $8.31 | +393.38% | 3 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $5.46 | +46.52% | 1 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 → $40 | $24.19 | +65.36% | 40 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 → $97 | $88.29 | +9.87% | 13 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $140 → $149 | $123.96 | +20.20% | 14 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $18 → $50 | $37.94 | +31.79% | 16 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $4.78 | +213.81% | 1 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $38 → $48 | $55.68 | -13.79% | 12 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $30 → $33 | $35.93 | -8.15% | 16 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $16.41 | - | 35 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 | $4.10 | +704.88% | 3 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $19.37 | -38.05% | 12 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 | $2.49 | +20.48% | 12 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $345 | $317.42 | +8.69% | 47 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 | $8.03 | +12.08% | 18 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $4.57 | +9.41% | 39 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18.00 | $11.13 | +61.73% | 6 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $96 → $103 | $116.65 | -11.70% | 61 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $155.00 | n/a | 1 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $68.81 | n/a | 2 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $67 → $25 | $3.58 | n/a | 2 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 → $15 | $23.16 | n/a | 2 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $8.20 | n/a | 1 | Mar 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 | $8.40 | n/a | 3 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $0.0001 | n/a | 1 | Jan 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $23 | $106.09 | n/a | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 → $8 | $9.17 | n/a | 10 | Jul 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $5.73 | n/a | 6 | Jul 18, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.40 | n/a | 5 | Jul 18, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $20 | $46.63 | n/a | 1 | Feb 17, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $136.30 | n/a | 3 | Dec 1, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $13.19 | n/a | 2 | Dec 1, 2014 |
Agios Pharmaceuticals
Jul 7, 2026
Maintained: Buy
Price Target: n/a
Current: $38.72
Upside: -
Parabilis Medicines
Jul 6, 2026
Initiated Coverage: Buy
Price Target: $40
Current: $29.06
Upside: +37.65%
Aura Biosciences
Jun 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $6.89
Upside: -
Sutro Biopharma
May 15, 2026
Rated: Buy
Price Target: $38 → $43
Current: $23.73
Upside: +81.21%
Tango Therapeutics
May 15, 2026
Rated: Buy
Price Target: $10 → $55
Current: $27.64
Upside: +98.99%
Immunome
May 15, 2026
Maintained: Buy
Price Target: $40 → $33
Current: $22.20
Upside: +48.65%
Damora Therapeutics
May 15, 2026
Maintained: Buy
Price Target: $46 → $51
Current: $30.24
Upside: +68.65%
Compass Therapeutics
Apr 27, 2026
Maintained: Buy
Price Target: $7 → $11
Current: $2.10
Upside: +423.81%
Adlai Nortye
Mar 20, 2026
Initiated Coverage: Buy
Price Target: $23
Current: $11.35
Upside: +102.64%
BridgeBio Oncology Therapeutics
Mar 6, 2026
Reiterated: Buy
Price Target: $41
Current: $8.31
Upside: +393.38%
Jan 23, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $5.46
Upside: +46.52%
Nov 19, 2025
Maintained: Buy
Price Target: $24 → $40
Current: $24.19
Upside: +65.36%
Nov 17, 2025
Maintained: Buy
Price Target: $70 → $97
Current: $88.29
Upside: +9.87%
Nov 17, 2025
Maintained: Buy
Price Target: $140 → $149
Current: $123.96
Upside: +20.20%
Nov 10, 2025
Rated: Buy
Price Target: $18 → $50
Current: $37.94
Upside: +31.79%
Oct 31, 2025
Initiated Coverage: Buy
Price Target: $15
Current: $4.78
Upside: +213.81%
Oct 21, 2025
Upgraded: Buy
Price Target: $38 → $48
Current: $55.68
Upside: -13.79%
Oct 21, 2025
Maintained: Hold
Price Target: $30 → $33
Current: $35.93
Upside: -8.15%
Sep 4, 2025
Maintained: Buy
Price Target: n/a
Current: $16.41
Upside: -
Aug 13, 2025
Maintained: Buy
Price Target: $33
Current: $4.10
Upside: +704.88%
Aug 12, 2025
Reiterated: Buy
Price Target: $12
Current: $19.37
Upside: -38.05%
Aug 11, 2025
Maintained: Hold
Price Target: $3
Current: $2.49
Upside: +20.48%
Aug 7, 2025
Reiterated: Buy
Price Target: $345
Current: $317.42
Upside: +8.69%
Aug 7, 2025
Maintained: Hold
Price Target: $9
Current: $8.03
Upside: +12.08%
Aug 7, 2025
Reiterated: Hold
Price Target: $5
Current: $4.57
Upside: +9.41%
Aug 5, 2025
Maintained: Buy
Price Target: $18.00
Current: $11.13
Upside: +61.73%
Jul 30, 2025
Maintained: Buy
Price Target: $96 → $103
Current: $116.65
Upside: -11.70%
Feb 26, 2025
Maintained: Buy
Price Target: n/a
Current: $155.00
Upside: n/a
Dec 10, 2024
Maintained: Buy
Price Target: n/a
Current: $68.81
Upside: n/a
Feb 7, 2023
Maintained: Buy
Price Target: $67 → $25
Current: $3.58
Upside: n/a
Feb 7, 2023
Maintained: Hold
Price Target: $20 → $15
Current: $23.16
Upside: n/a
Mar 21, 2022
Maintained: Buy
Price Target: n/a
Current: $8.20
Upside: n/a
May 7, 2021
Maintained: Hold
Price Target: $10
Current: $8.40
Upside: n/a
Jan 17, 2018
Initiated Coverage: Buy
Price Target: $10
Current: $0.0001
Upside: n/a
Nov 1, 2017
Maintained: Hold
Price Target: $23
Current: $106.09
Upside: n/a
Jul 14, 2017
Maintained: Hold
Price Target: $16 → $8
Current: $9.17
Upside: n/a
Jul 18, 2016
Reiterated: Sell
Price Target: n/a
Current: $5.73
Upside: n/a
Jul 18, 2016
Reiterated: Buy
Price Target: n/a
Current: $1.40
Upside: n/a
Feb 17, 2016
Upgraded: Buy
Price Target: $20
Current: $46.63
Upside: n/a
Dec 1, 2014
Maintained: Hold
Price Target: n/a
Current: $136.30
Upside: n/a
Dec 1, 2014
Maintained: Hold
Price Target: n/a
Current: $13.19
Upside: n/a